Showing results (491-500 of 678) with videos related to

Sort By:
Pageof 68
American Journal of Physiology. Cell Physiology|January 29, 2011
Neuropeptide Y inhibits cholangiocarcinoma cell growth and invasionSharon DeMorrow, Paolo Onori, Julie Venter, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|June 30, 2024
The tumor microenvironment of VETC+ hepatocellular carcinoma is enriched of immunosuppressive TAMs spatially close to endothelial cellsCamilla De Carlo, Roy Rosman-Nathanson, Barbara Durante, et al.
Clinical Reviews in Allergy & Immunology|November 29, 2017
Geoepidemiology of Primary Biliary Cholangitis: Lessons from SwitzerlandBenedetta Terziroli Beretta-Piccoli, Guido Stirnimann, Andreas Cerny, et al.
Hepatology (Baltimore, Md.)|January 19, 2017
The fingerprint of antimitochondrial antibodies and the etiology of primary biliary cholangitisZongwen Shuai, Jinjun Wang, Madhu Badamagunta, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 29, 2019
Secretin/secretin receptor signaling mediates biliary damage and liver fibrosis in early-stage primary biliary cholangitisLindsey Kennedy, Heather Francis, Pietro Invernizzi, et al.
Updates in Surgery|June 18, 2021
Compliance with evidence-based clinical guidelines in the management of acute biliary pancreatitis: the MANCTRA-1 study protocolMauro Podda, Gianluca Pellino, Federico Coccolini, et al.
Journal of Nephrology|August 24, 2022
Negative prognostic impact of electrolyte disorders in patients hospitalized for Covid-19 in a large multicenter studySimonetta Genovesi, Giuseppe Regolisti, Paola Rebora, et al.
Hepatology (Baltimore, Md.)|October 5, 2021
E. coli and the etiology of human PBC: Antimitochondrial antibodies and spreading determinantsYao Yang, Jinjung Choi, Ying Chen, et al.
Pageof 68